Postmenopausal tamoxifen treatment and endometrial pathology
- PMID: 7885659
- DOI: 10.1097/00006254-199412000-00006
Postmenopausal tamoxifen treatment and endometrial pathology
Abstract
Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical